Stockscreener 앱 받기
10.31
0.10%
-0.010
전일 마감가:
$10.32
열려 있는:
$10.31
하루 거래량:
20,158
Relative Volume:
0.52
시가총액:
$345.56M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.10%
1개월 성능:
+0.39%
6개월 성능:
+2.28%
1년 성능:
+0.00%
1일 변동 폭
$10.31
$10.31
1주일 범위
$10.30
$10.32
52주 변동 폭
$9.96
$10.35
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
명칭
Drugs Made In America Acquisition Corp
전화
954-870-3104
주소
2 PELICAN DR., FORT LAUDERDALE
DMAA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.31 | 345.56M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.34 | 1.86B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
17.86 | 1.00B | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.03 | 592.00M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.37 | 571.27M | 0 | 0 | 0 | 0.00 |
|
AAM
Aa Mission Acquisition Corp
|
10.60 | 466.12M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스
Why Drugs Made In America Acquisition Corp. stock is seen as undervaluedJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Why Drugs Made In America Acquisition Corp. stock is recommended by analystsWeekly Market Summary & Momentum Based Trading Ideas - newser.com
Strategies to average down on Drugs Made In America Acquisition Corp.Swing Trade & Technical Pattern Based Buy Signals - newser.com
Is Drugs Made In America Acquisition Corp. Equity Right trending in predictive chart models2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Is Drugs Made In America Acquisition Corp. stock a dividend growth opportunity2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Published on: 2025-11-02 23:21:11 - newser.com
News impact scoring models applied to Drugs Made In America Acquisition Corp.July 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
Full technical analysis of Drugs Made In America Acquisition Corp. Equity Right stock - newser.com
How Drugs Made In America Acquisition Corp. stock valuations compare to rivalsAnalyst Downgrade & Accurate Buy Signal Alerts - newser.com
Is Drugs Made In America Acquisition Corp. stock trading near support levelsMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
Published on: 2025-11-02 12:34:43 - newser.com
What technical models suggest about Drugs Made In America Acquisition Corp. Equity Right’s comebackJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Using data models to predict Drugs Made In America Acquisition Corp. stock movementJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
Pattern recognition hints at Drugs Made In America Acquisition Corp. upsideEarnings Growth Summary & Short-Term High Return Strategies - newser.com
Pfizer Inc. - Britannica
Op-Ed: Jared Whitley: Consolidation in weight loss R&D would jeopardize President Trump’s drug pricing wins - Washington Reporter
How Drugs Made In America Acquisition Corp. Equity Right stock reacts to bond yields2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Will VRNA stock reach Wall Street targetsExit Point & Daily Technical Forecast Reports - newser.com
Published on: 2025-10-31 05:15:32 - newser.com
Real time breakdown of Drugs Made In America Acquisition Corp. stock performanceQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Why analysts upgrade Drugs Made In America Acquisition Corp. stockPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
How to track smart money flows in Drugs Made In America Acquisition Corp. Equity RightWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
Published on: 2025-10-30 23:22:41 - newser.com
Drugs Made In America Acquisition Corp. stock chart pattern explained2025 Performance Recap & Entry Point Strategy Guides - newser.com
How to read the order book for Drugs Made In America Acquisition Corp.Insider Buying & Expert Verified Stock Movement Alerts - newser.com
Custom strategy builders for tracking Drugs Made In America Acquisition Corp. Equity RightQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Drugs Made In America Acquisition Corp (DMAA) 재무 분석
Drugs Made In America Acquisition Corp (DMAA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.18%
9.62%
자본화:
|
볼륨(24시간):